Skip to main content
. Author manuscript; available in PMC: 2010 Nov 30.
Published in final edited form as: Cell Cycle. 2008 Dec 22;7(23):3618–3621. doi: 10.4161/cc.7.23.7064

Figure 1.

Figure 1

The Mre11 complex and Chk2 in apoptosis and tumor suppression. (A) The Mre11 complex (MRN) functions at multiple stages in apoptotic signaling; the activation of ATM, which is impaired by the Mre11ATLD1 allele, and the promotion of ATM activity by the C-terminal domain of Nbs1 that is deleted in the Nbs1ΔC allele. ATM phosphorylates Chk2 and this requires the Mre11 complex, but Chk2 promotes apoptosis in the absence of ATM, defining a parallel pathway. 4,5 (B) The influence of the Mre11 complex and Chk2 on tumorigenesis. Alleles that impair the metabolism of DNA replication associated breaks in S and G2 (Mre11ATLD1, Nbs1ΔB or Brca1Δ or Δ11) predispose tumors in the absence of Chk2.5,25,26 DSBs arising from the deficient repair of programmed breaks, as in DNA-PKcs deficient mice (Prkdcscid), are not sufficient to promote tumorigenesis in the absence of Chk2.5 The G1/S and G2/M checkpoints are indicated in red.